Cargando…
TAC‐101 (4‐[3,5‐bis(trimethylsilyl)benzamido]benzoic acid) Inhibits Spontaneous Mediastinal Lymph Node Metastasis Produced by Orthotopic Implantation of Lewis Lung Carcinoma
The anti‐tumor and anti‐metastatic effects of 4‐[3,5‐bis(trimethylsilyl)benzamido]benzoic acid (TAC‐101) were investigated using our established lung cancer model. Orthotopic implantation of Lewis lung carcinoma (LLC) cells into the lung parenchyma produced a solitary tumor nodule in the lung follow...
Autores principales: | Murakami, Koji, Yamaura, Takeshi, Suda, Kazuhito, Ohie, Shinji, Shibata, Jiro, Toko, Toshiyuki, Yamada, Yuji, Saiki, Ikuo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
1999
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5926012/ https://www.ncbi.nlm.nih.gov/pubmed/10622538 http://dx.doi.org/10.1111/j.1349-7006.1999.tb00705.x |
Ejemplares similares
-
Mediastinal lymph node metastasis model by orthotopic intrapulmonary implantation of Lewis lung carcinoma cells in mice
por: Doki, Y, et al.
Publicado: (1999) -
2-Methyl-4-(2-methylbenzamido)benzoic acid
por: He, Fei-Fei, et al.
Publicado: (2011) -
Crystal structure of 2-(4-chlorobenzamido)benzoic acid
por: Moreno-Fuquen, Rodolfo, et al.
Publicado: (2015) -
Crystal structure of 4-benzamido-2-hydroxybenzoic acid
por: Shahid, Muhammad, et al.
Publicado: (2015) -
A Potential Use of a Synthetic Retinoid TAC‐101 as an Orally Active Agent That Blocks Angiogenesis in Liver Metastases of Human Stomach Cancer Cells
por: Oikawa, Tsutomu, et al.
Publicado: (2001)